Laboratorios Richmond SACIF

Laboratorios Richmond SACIF FCF per Share

The Free Cash Flow per Share of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is -39.47 ARS. In the previous year, Free Cash Flow per Share was -186.03 ARS — a change of -78.78% (higher).

FCF per Share

-39.47ARS

YoY

-78.78%

Last updated:

Free Cash Flow per Share of Laboratorios Richmond SACIF is 2024 -39.47 ARS. Free Cash Flow per Share of Laboratorios Richmond SACIF was 2023 -186.03 ARS. It decreases by -78.78% higher compared to the previous year.

The Laboratorios Richmond SACIF FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
-1.21 ARS
Jan 1, 2018
-7.08 ARS
Jan 1, 2019
-6.08 ARS
Jan 1, 2020
-13.61 ARS
Jan 1, 2021
-52.93 ARS
Jan 1, 2022
-146.19 ARS
Jan 1, 2023
-186.03 ARS
Jan 1, 2024
-39.47 ARS
The Laboratorios Richmond SACIF FCF per Share history
YEARFCF per ShareYoY
-39.47ARS-78.78%
-186.03ARS+27.25%
-146.19ARS+176.19%
-52.93ARS+288.81%
-13.61ARS+123.84%
-6.08ARS-14.08%
-7.08ARS+486.80%
-1.21ARS+203.07%
-0.40ARS-21.63%
-0.51ARS+54.74%
-0.33ARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Free Cash Flow per Share of Laboratorios Richmond SACIF is -39.47 ARS in 2024.

Free Cash Flow per Share of Laboratorios Richmond SACIF changed from -186.03 ARS to -39.47 ARS, representing a -78.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF